Lenalidomide
Sold as Revlimid, Lenalidomide DRL, Myelid, Lenalidomide cipla, Eurolen, Neoled, Adco lenalidomide, Lenalidomide forrester, Datrenal, Cancalid, Linadex
3-(7-Amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
Drag to rotate. Structure from PubChem CID 216326.
Background
Registration
- Applicants
- 8
- Registrations
- 59
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Key Oncologics (Pty) LtdCancelled | Revlimid | 5 mg, 10 mg, 15 mg, 25 mg | 470507, 470508, 470509, 470510 | S4 | None |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd. | Lenalidomide DRL | 5, 10, 15, 25 | 520791, 520792, 520793, 520794 | S4 | PIPIL |
| Cipla Medpro (Pty) LtdCertificate held by Cipla Medpro (Pty) Ltd.3 of 8 cancelled | Myelid, Lenalidomide cipla | 5, 10, 15, 25 | 530371, 530372, 530373, 530374.371, 530375.372, 530376.373, 550294, 550295.294 | S4 | PIPIL |
| Eurolab (Pty) LtdCertificate held by Eurolab (Pty) Ltd_ | Eurolen | 5, 10, 15, 25 | 530739, 530740, 530741, 530742 | S4 | PIPIL |
| Adcock ingram limited7 of 14 cancelled | Neoled, Adco lenalidomide | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg | 540540, 540541, 540542, 540543, 540544, 540545, 540546, 540547.54, 540548.541, 540549.542, 540550.543, 540551.544, 540552.545, 540553.546 | S4 | None |
| Forrester Pharma (Pty) Ltd | Lenalidomide forrester | 2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg, 20 mg, 25 mg | 540713, 540714, 540715, 540716, 540717, 540718, 540719 | S4 | None |
| Aurogen South Africa (Pty) Ltd | Datrenal, Cancalid | 2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg, 20 mg, 25 mg | 560511, 560512, 560513, 560514, 560515, 560516, 560517, 560518.511, 560519.512, 560520.513, 560521.514, 560522.515, 560523.516, 560524.517 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Linadex | 5 mg, 10 mg, 15 mg, 25 mg | 590286, 590287, 590288, 590289 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Revlimid 5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 mg | 47050747/32/0507 | Cancelled | S4 | None |
| Revlimid 10 MG EACH CAPSULE CONTAINS LENALIDOMIDE 10,0 mg | 10 mg | 47050847/32/0508 | Cancelled | S4 | None |
| Revlimid 15 MG EACH CAPSULE CONTAINS LENALIDOMIDE 15,0 mg | 15 mg | 47050947/32/0509 | Cancelled | S4 | None |
| Revlimid 25 MG EACH CAPSULE CONTAINS LENALIDOMIDE 25,0 mg | 25 mg | 47051047/32/0510 | Cancelled | S4 | None |
| Lenalidomide DRL 5 EACH HARD GELATIN CAPSULE CONTAINS: LENALIDOMIDE 5,0 mg | 5Capsules | 52079152/26/0791Approved 14 April 2023 | Registered | S4 | PIPIL |
| Lenalidomide DRL 10 EACH HARD GELATIN CAPSULE CONTAINS: LENALIDOMIDE 10,0 mg | 10Capsules | 52079252/26/0792Approved 14 April 2023 | Registered | S4 | PIPIL |
| Lenalidomide DRL 15 EACH HARD GELATIN CAPSULE CONTAINS: LENALIDOMIDE 15,0 mg | 15Capsules | 52079352/26/0793Approved 14 April 2023 | Registered | S4 | PIPIL |
| Lenalidomide DRL 25 EACH HARD GELATIN CAPSULE CONTAINS: LENALIDOMIDE 25,0 mg | 25Capsules | 52079452/26/0794Approved 14 April 2023 | Registered | S4 | PIPIL |
| Myelid 10 EACH CAPSULE CONTAINS: LENALIDOMIDE 10,0 mg | 10 | 53037153/32/0371 | Cancelled | S4 | None |
| Myelid 15 EACH CAPSULE CONTAINS: LENALIDOMIDE 15,0 mg | 15 | 53037253/32/0372 | Cancelled | S4 | None |
| Myelid 25 EACH CAPSULE CONTAINS :LENALIDOMIDE 25,0 mg | 25 | 53037353/32/0373 | Cancelled | S4 | None |
| Lenalidomide 10 cipla EACH CAPSULE CONTAINS: LENALIDOMIDE 10,0 mg | 10Capsules | 530374.37153/32/0374.371Approved 18 March 2021 | Registered | S4 | PIPIL |
| Lenalidomide 15 cipla EACH CAPSULE CONTAINS:LENALIDOMIDE 15,0 mg | 15Capsules | 530375.37253/32/0375.372Approved 18 March 2021 | Registered | S4 | PIPIL |
| Lenalidomide 25 cipla EACH CAPSULE CONTAINS:LENALIDOMIDE 25,0 mg | 25Capsules | 530376.37353/32/0376.373Approved 18 March 2021 | Registered | S4 | PIPIL |
| Eurolen 5 EACH CAPSULE CONTAINS: LENALIDOMIDE 5,0 mg | 5Hard capsules | 53073953/32/0739Approved 27 November 2020 | Registered | S4 | PIPIL |
| Eurolen 10 EACH CAPSULE CONTAINS: LENALIDOMIDE 10,0 mg | 10Hard capsules | 53074053/32/0740Approved 27 November 2020 | Registered | S4 | PIPIL |
| Eurolen 15 EACH CAPSULE CONTAINS: LENALIDOMIDE 15,0 mg | 15Hard capsules | 53074153/32/0741Approved 27 November 2020 | Registered | S4 | PIPIL |
| Eurolen 25 EACH CAPSULE CONTAINS: LENALIDOMIDE 25,0 mg | 25Hard capsules | 53074253/32/0742Approved 27 November 2020 | Registered | S4 | PIPIL |
| Neoled 2.5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 2,5 mg | 2.5 mg | 54054054/32/0540 | Registered | S4 | None |
| Neoled 5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 mg | 54054154/32/0541 | Registered | S4 | None |
| Neoled 7.5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 7,5 mg | 7.5 mg | 54054254/32/0542 | Registered | S4 | None |
| Neoled 10 MG EACH CAPSULE CONTAINS LENALIDOMIDE 10,0 mg | 10 mg | 54054354/32/0543 | Registered | S4 | None |
| Neoled 15 MG EACH CAPSULE CONTAINS LENALIDOMIDE 15,0 mg | 15 mg | 54054454/32/0544 | Registered | S4 | None |
| Neoled 20 MG EACH CAPSULE CONTAINS LENALIDOMIDE 20,0 mg | 20 mg | 54054554/32/0545 | Registered | S4 | None |
| Neoled 25 MG EACH CAPSULE CONTAINS LENALIDOMIDE 25,0 mg | 25 mg | 54054654/32/0546 | Registered | S4 | None |
| Adco lenalidomide 2.5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 2,5 mg | 2.5 mg | 540547.5454/32/0547.540 | Cancelled | S4 | None |
| Adco lenalidomide 5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 mg | 540548.54154/32/0548.541 | Cancelled | S4 | None |
| Adco lenalidomide 7.5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 7,5 mg | 7.5 mg | 540549.54254/32/0549.542 | Cancelled | S4 | None |
| Adco lenalidomide 10 MG EACH CAPSULE CONTAINS LENALIDOMIDE 10,0 mg | 10 mg | 540550.54354/32/0550.543 | Cancelled | S4 | None |
| Adco lenalidomide 15 MG EACH CAPSULE CONTAINS LENALIDOMIDE 15,0 mg | 15 mg | 540551.54454/32/0551.544 | Cancelled | S4 | None |
| Adco lenalidomide 20 MG EACH CAPSULE CONTAINS LENALIDOMIDE 20,0 mg | 20 mg | 540552.54554/32/0552.545 | Cancelled | S4 | None |
| Adco lenalidomide 25 MG EACH CAPSULE CONTAINS LENALIDOMIDE 25,0 mg | 25 mg | 540553.54654/32/0553.546 | Cancelled | S4 | None |
| Lenalidomide 2,5 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 2,5 mg | 2,5 mg | 54071354/32/0713 | Registered | S4 | None |
| Lenalidomide 5 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 mg | 54071454/32/0714 | Registered | S4 | None |
| Lenalidomide 7,5 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 7,5 mg | 7,5 mg | 54071554/32/0715 | Registered | S4 | None |
| Lenalidomide 10 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 10,0 mg | 10 mg | 54071654/32/0716 | Registered | S4 | None |
| Lenalidomide 15 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 15,0 mg | 15 mg | 54071754/32/0717 | Registered | S4 | None |
| Lenalidomide 20 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 20,0 mg | 20 mg | 54071854/32/0718 | Registered | S4 | None |
| Lenalidomide 25 MG forrester EACH CAPSULE CONTAINS LENALIDOMIDE 25,0 mg | 25 mg | 54071954/32/0719 | Registered | S4 | None |
| Myelid 5 EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 | 55029455/32/0294 | Registered | S4 | None |
| Lenalidomide cipla 5 EACH CAPSULE CONTAINS: LENALIDOMIDE 5,0 mg | 5Capsules | 550295.29455/32/0295.294Approved 18 March 2021 | Registered | S4 | PIPIL |
| Datrenal 2,5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 2,5 mg | 2,5 mg | 56051156/32/0511 | Registrered | S4 | None |
| Datrenal 5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 mg | 56051256/32/0512 | Registrered | S4 | None |
| Datrenal 7,5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 7,5 mg | 7,5 mg | 56051356/32/0513 | Registrered | S4 | None |
| Datrenal 10 MG EACH CAPSULE CONTAINS LENALIDOMIDE 10,0 mg | 10 mg | 56051456/32/0514 | Registrered | S4 | None |
| Datrenal 15 MG EACH CAPSULE CONTAINS LENALIDOMIDE 15,0 mg | 15 mg | 56051556/32/0515 | Registrered | S4 | None |
| Datrenal 20 MG EACH CAPSULE CONTAINS LENALIDOMIDE 20,0 mg | 20 mg | 56051656/32/0516 | Registrered | S4 | None |
| Datrenal 25 MG EACH CAPSULE CONTAINS LENALIDOMIDE 25,0 mg | 25 mg | 56051756/32/0517 | Registrered | S4 | None |
| Cancalid 2,5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 2,5 mg | 2,5 mg | 560518.51156/32/0518.511 | Registrered | S4 | None |
| Cancalid 5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 5,0 mg | 5 mg | 560519.51256/32/0519.512 | Registrered | S4 | None |
| Cancalid 7,5 MG EACH CAPSULE CONTAINS LENALIDOMIDE 7,5 mg | 7,5 mg | 560520.51356/32/0520.513 | Registrered | S4 | None |
| Cancalid 10 MG EACH CAPSULE CONTAINS LENALIDOMIDE 10,0 mg | 10 mg | 560521.51456/32/0521.514 | Registrered | S4 | None |
| Cancalid 15 MG EACH CAPSULE CONTAINS LENALIDOMIDE 15,0 mg | 15 mg | 560522.51556/32/0522.515 | Registrered | S4 | None |
| Cancalid 20 MG EACH CAPSULE CONTAINS LENALIDOMIDE 20,0 mg | 20 mg | 560523.51656/32/0523.516 | Registrered | S4 | None |
| Cancalid 25 MG EACH CAPSULE CONTAINS LENALIDOMIDE 25,0 mg | 25 mg | 560524.51756/32/0524.517 | Registrered | S4 | None |
| Linadex 5 MG EACH CAPSULE CONTAINS: LENALIDOMIDE 5,0 mg | 5 mg | 59028659/26/0286 | Registered | S4 | None |
| Linadex 10 MG EACH CAPSULE CONTAINS: LENALIDOMIDE 10,0 mg | 10 mg | 59028759/26/0287 | Registered | S4 | None |
| Linadex 15 MG EACH CAPSULE CONTAINS: LENALIDOMIDE 15,0 mg | 15 mg | 59028859/26/0288 | Registered | S4 | None |
| Linadex 25 MG EACH CAPSULE CONTAINS: LENALIDOMIDE 25,0 mg | 25 mg | 59028959/26/0289 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Lenalidomide
S4: Lenalidomide
Consolidated Schedules 06 July 2026, line 6886
Pharmacological class: Other substances or agents (class 32)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.